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Abstract
The symptoms of joint hypermobility extend beyond articular pain. Hypermobile
people commonly experience autonomic symptoms (dysautonomia), and anxiety or
related psychological issues. We tested whether dysautonomia might mediate the
association between hypermobility and anxiety in adults diagnosed with mental
health disorders and/or neurodevelopmental conditions (hereon referred to as
patients), by quantifying joint hypermobility and symptoms of autonomic dysfunc-
tion. Prevalence of generalized joint laxity (hypermobility) in 377 individuals with
diagnoses of mental health disorders and/or neurodevelopmental conditions was
compared to prevalence recorded in the general population. Autonomic symptom
burden was compared between hypermobile and non-hypermobile patients. Media-
tion analysis explored relationships between hypermobility, autonomic dysfunction,
and anxiety. Patient participants had elevated prevalence of generalized joint laxity
(38%) compared to the general population rate of 19% (odds ratio: 2.54 [95%
confidence interval: 2.05, 3.16]). Hypermobile participants reported significantly
more autonomic symptoms. Symptoms of orthostatic intolerance mediated the rela-
tionship between hypermobility and diagnosis of an anxiety disorder. Patients with
mental health disorders and/or neurodevelopmental conditions have high rates of
joint hypermobility. Accompanying autonomic dysfunction mediates the association
between joint hypermobility and clinical anxiety status. Increased recognition of
this association can enhance mechanistic understanding and improve the manage-
ment of multimorbidity expressed in physical symptoms and mental health
difficulties.
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1 | INTRODUCTION
Joint hypermobility refers to the capacity for a joint to move beyond
what are considered normal limits (Baeza-Velasco, Sinibaldi, &
Castori, 2018) as a result of ligamentous laxity (Clinch et al., 2011;
Sobey, 2015) and is a representation of variant connective tissue,
including collagen and other structural elements of the extracellular
matrix. Generalized joint hypermobility is commonly assessed using
the Beighton Scale, which quantifies hypermobility across specific
joints (fifth finger metacarpal-phalangeal joints, wrists, knees, elbows,
and spine) Beighton, Solomon, & Soskolne, 1973; Junge et al., 2019).
For the purpose of this study, generalized joint laxity (GJL) is inferred
if an individual achieves a Beighton score of 4 or more (i.e., increase
range of movement in 4 of 9 joints tested). The prevalence of GJL is
estimated between 11 and 30% of the population and is predomi-
nantly manifested in those assigned female at birth (Junge
et al., 2019; Juul-Kristensen et al., 2017; Mulvey et al., 2013). Also,
there are reported differences between ethnicities on the prevalence
of GJL (e.g., higher prevalence in African and Asian populations
[Hakim, Malfait, & De Paepe, 2010; Reuter & Fichthorn, 2019]
compared to European populations). GJL is often associated with
musculoskeletal symptoms, particularly pain (Clinch et al., 2011;
Sobey, 2015), where hypermobility spectrum disorder (HSD) or hyper-
mobile Ehlers–Danlos Syndrome (hEDS) may be diagnosed (hereon
symptomatic hypermobility), replacing the former constructs of joint
hypermobility syndrome and EDS-III/HT. The prevalence of symptom-
atic hypermobility in general practice (community physician) settings
in the United Kingdom is reported as 194.2 per 100,000 people but
the condition is thought to be under-diagnosed and the prevalence of
HSD and hEDS are suspected to be much higher than initially thought
(Demmler et al., 2019). To our knowledge, further population-level
data on the prevalence of diagnosed symptomatic hypermobility con-
ditions are not available; however, GJL prevalence data exist (Clinch
et al., 2011; Mulvey et al., 2013). From the available data, GJL and
clinically significant symptomatic hypermobility seem to occur at high
rates across populations, carrying major health costs implications,
which may not yet be fully quantified or recognized due to high rates
of under/misdiagnosis and co-occurring impact on both mental and
physical health.
In addition to pain, musculoskeletal, and skin-related symptoms
(Demmler et al., 2019), strong associations are observed between
hypermobility and autonomic dysfunction (Hakim et al., 2017). Auto-
nomic dysfunction impairs automatic physiological regulation across
bodily systems affecting heart rate and blood pressure, respiration,
digestion, urination, defecation, metabolism, the production of bodily
fluids (including sweat, saliva, and tears), and the control of body tem-
perature (Hakim et al., 2017; Smith, 2017). Within the hypermobility
literature, most attention is paid to cardiovascular autonomic dysfunc-
tion: Up to 80% of people with hypermobility experience orthostatic
intolerance (including postural tachycardia (Mathias et al., 2011; Wells
et al., 2018) and postural hypotension, characterized by symptoms
such as light-headedness when standing upright (Celletti et al., 2017;
Chan, Krahe, Lee, & Nicholson, 2019; Stewart, 2013), and autonomic
neurally mediated syncope. Postural tachycardia syndrome (PoTS)
may be diagnosed when objective physiological criteria provide an
explanatory account for orthostatic intolerance, and there is a phe-
nomenological overlap between anxiety symptoms and those of
orthostatic intolerance. Hence, the (common) concurrence of hyper-
mobility and orthostatic intolerance represents an expression of mul-
timorbidity (the presence of two or more long-term health conditions
[National Institute for Health and Care Excellence, 2018]). There is a
need to recognize the impact of multimorbidity and rethink the preva-
iling divisions in clinical medicine, education, and treatment guidelines
that are frequently based on single systems, especially given the inter-
action between physical and mental health problems makes each har-
der to treat (Whitty et al., 2020).
There is also growing recognition of associations between hyper-
mobility and other non-cardiovascular autonomic symptomatology.
These include: gastrointestinal disorders including irritable bowel syn-
drome (Fikree, Chelimsky, Collins, Kovacic, & Aziz, 2017), bladder dys-
function (De Wandele et al., 2014), hyperhidrosis (excessive sweating
indicating sudomotor dysregulation) (Castori, 2012; De Wandele
et al., 2014) and secretomotor symptoms (including dry mouth or dry
eyes) (Kumar & Lenert, 2017; Wang, Fealey, Gehrking, & Low, 2008).
These symptoms add to the burden on quality of life (Fikree
et al., 2017; Hakim et al., 2017). Together, the combination of
autonomic dysfunction with chronic pain has a multi-systemic and
detrimental impact on the lives of hypermobile people (Bulbena
et al., 2017).
Further multimorbidity arises through a complex association
between hypermobility and vulnerabilities to mental health disorders
and/or the presence of neurodevelopmental conditions. A consistent
and common observation is that compared to non-hypermobile indi-
viduals, people with hypermobility are significantly more likely to
experience symptomatic anxiety (Bulbena et al., 2011; Bulbena
et al., 2017; Smith et al., 2014). Similarly, it has also been shown that
people with hypermobility have a higher probability of experiencing
depression (Smith et al., 2014) or bipolar disorder (Cederlöf
et al., 2016). There is also growing evidence that hypermobility is
more common among autistic people and those with attention deficit
hyperactivity disorder (Cederlöf et al., 2016) and Tourette syndrome
(Csecs et al., 2020). Preliminary evidence in a small sample suggests
hypermobility is more common in people with anorexia nervosa (Goh,
Olver, Huang, Millard, & O'Callaghan, 2013). It may well be that these
conditions have commonality in shared biological mechanisms includ-
ing dysautonomia. While we may not yet have a comprehensive
mechanistic understanding of why hypermobility is more prevalent in
people with mental health and/or neurodevelopmental conditions
compared to the general population, the recognition of such associa-
tions represents an important step towards implementing joined-up
therapeutic approaches to manage multimorbidity and reduced quality
of life, reduced life expectancy, and increased functional difficulties
inherent in the experience of two or more long-term health conditions
(National Institute for Health and Care Excellence, 2018).
Despite the aforementioned relationships, to our knowledge,
there has been no direct characterization within those with mental
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health conditions with regards to autonomic dysfunction and its links
to hypermobility in people. Such characterization is needed to map
the associated burden on quality of life (Fikree et al., 2017; Hakim
et al., 2017) and guide clinical services in the provision of more effec-
tive, holistic, and targeted interventions for patients with interacting
challenges to psychological and physical health (Bulbena et al., 2017).
Chronic and severe psychiatric disorders increase the likelihood of
physical health problems (including cardiovascular disease, respiratory
disease, and infections) and premature mortality (Liu et al., 2017;
Osborn, 2001). Correspondingly, if autonomic dysfunction can be
shown to have a mediating relationship in people with hypermobility
and mental health conditions, individually focused interventions to
improve autonomic function may help alleviate many of the enmeshed
psychological and physical symptoms experienced by hypermobile
individuals (Davies et al., 2021; Eccles & Davies, 2021).
In some forms of PoTS, heart rate acceleration is thought to com-
pensate for dysfunctional vasoconstriction and may give rise to physi-
ological symptoms (e.g., palpitations and light-headedness) that are
shared with panic and anxiety states (Eccles, Owens, Mathias,
Umeda, & Critchley, 2015). Coupled with differences in interoception
and brain structure and function (e.g., amygdala and insular cortex)
associated with hypermobility (Eccles et al., 2012; Mallorqui-Bague
et al., 2014), such deregulated responses are likely to affect neural
processes supporting emotional feelings (Critchley, 2009; Seth,
Suzuki, & Critchley, 2011).
The aim of this study is to quantify the frequency of GJL and
autonomic dysfunction in those with diagnosed mental health disor-
ders and/or neurodevelopmental conditions. We hypothesized that
people with diagnosed mental health disorders and/or neu-
rodevelopmental conditions will have higher rates of GJL compared to
a large population cohort study (prevalence of GJL in adolescence in
the Avon Longitudinal Study of Parents and Children [ALSPAC] cohort
[Clinch et al., 2011]). We will use these data because this cohort rep-
resents the most robust indication of prevalence of GJL in the general
population so far and is similar to the rates found in a large population
survey of adults that assessed GJL by self-report (Mulvey et al., 2013).
We also hypothesized that hypermobile people with diagnosed mental
health disorders and/or neurodevelopmental conditions will be more
likely to experience autonomic dysfunction across different organ sys-
tems compared to participants who are not hypermobile. Since hyper-
mobility is more common in those assigned female at birth, we also
proposed that more assigned female at birth than assigned male indi-
viduals in our study would have GJL and would experience more auto-
nomic symptoms. We also postulated that symptoms of autonomic
dysfunction, specifically orthostatic intolerance, would mediate the
relationship between hypermobility and anxiety status.
2 | MATERIALS AND METHODS
2.1 | Participants and ethical considerations
The study enrolled a total of 377 participants from community mental
health centers and specialist mental health centers in Sussex with
appropriate ethical approvals (NRES Ethics Committee [South East
Coast] [12.LO.1942]). Full informed consent was obtained and the
study was conducted according to the standards of the Declaration of
Helsinki. Data for the comparison group were derived from the
ALSPAC birth cohort study (Clinch et al., 2011) where the Beighton
score was available for 6,022 adolescents from the general popula-
tion. While these data were collected in adolescents, the levels of GJL
in this sample are comparable to that shown in adults (18% of the
population) (Mulvey et al., 2013).
2.2 | Measures and materials
The Autonomic Questionnaire and Quality of Life Score (AQQoL) is a
self-report questionnaire that measures symptoms of autonomic dys-
function (Iodice, 2013). It includes subscales of symptoms related to:
orthostatic intolerance (items 1–9), gastrointestinal (items 10–13),
bladder (items 14–15), secretomotor (items 16–18), sudomotor (items
19–21), and sleep (items 41–45). Participants were asked to rate how
often they experienced symptoms of autonomic dysfunction on a
5-point Likert scale (from “no” to “yes – daily”), for example, “do you
feel dizzy or lightheaded?”. Within the AQQol, musculoskeletal symp-
toms (predominately pain—items 27–40) were also surveyed (e.g., “do
you have any of the following symptoms? a) pains in the knees b)
pains in the fingers”). Participants were asked to rate these questions
on a 3-point Likert scale in relation to frequency (from “no” to “yes –
for longer than 3 months”). In scoring this musculoskeletal symptom
subscale, items relating to the Beighton Scoring System (below) were
omitted for group comparisons between hypermobile and non-
hypermobile participants as hypermobile participants would naturally
score higher. This represented a minor departure from the original
scoring (in Iodice, 2013).
The 9-item Beighton Scoring System (Beighton et al., 1973) was
followed by trained clinicians using objective measurements to assess
participants' joint laxity. Scores of ≥4 were indicative of generalized
joint laxity (GJL, also hereon referred to as “hypermobility”) in-line
with existing prevalence data (Clinch et al., 2011).
Clinical notes of participants were audited to determine clinical
diagnosis of psychiatric or neurodevelopmental condition.
2.3 | Data preparation for statistical analyses
Chi-square tests were used to test for group differences in the pro-
portion of people with GJL (i.e., a Beighton score of ≥4) between the
participants and the comparison group. The expected frequencies
were tested to ensure that the use of Pearson's chi-square was appro-
priate. Binary logistic regression was used to calculate the odds ratios
of having GJL for participants compared to the general population
comparison group. Differences between sexes in relation to GJL were
also tested using chi-square tests in (a) participants and (b) the com-
parison group. Binary logistic regression was used to calculate odds
ratios in relation to the likelihood of having generalized joint laxity
across sexes within (a) participants and (b) the comparison group.
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Chi-square tests were also used to ascertain if the proportion of
individuals with GJL and a specific mental health disorder or neu-
rodevelopmental condition differed between the two groups. Binary
logistic regression was then used to calculate odds ratios denoting the
likelihood of having GJL if an individual had a specific mental health
disorder or neurodevelopmental condition.
The autonomic symptom data were assessed for normality, and
given that data were non-parametric, Mann–Whitney U tests were
used to examine quantitative differences in AQQoL symptom sub-
scale scores between participants with and without GJL.
Factorial analyses of variance (ANOVAs) were used to test for
interaction effects between GJL, sex, and AQQoL symptom subscale
scores. Where symptom subscale scores did not follow a normal dis-
tribution (e.g., being positively skewed), these were transformed using
a square root transformation prior to factorial ANOVA completion
(Manikandan, 2010).
To investigate whether autonomic symptoms mediated the rela-
tionship between hypermobility and anxiety diagnosis, an estimation
of indirect effects was performed using PROCESS macro v3.5 by
Hayes (2017) within SPSS. The 95% bootstrapped confidence interval
(CI) for the indirect effect is based on 1,000 samples and considered
significant if the bootstrapped CIs do not cross zero. For this analysis,
the outcome variable was anxiety diagnosis, the predictor variable
was hypermobility (presence of GJL), and the mediator variable was
orthostatic intolerance symptoms score.
3 | RESULTS
3.1 | Demographic information
3.1.1 | Group data
Three-hundred and seventy-seven participants with diagnoses of men-
tal health disorders or neurodevelopmental conditions were included
in the study. Prevalence data reported in the ALSPAC birth cohort
study (Clinch et al., 2011) were used in the (adolescent) general popu-
lation comparison group, representing 6,022 individuals for whom a
Beighton score was available (which was collected outside of this
study and the raw data were not included in our study). Table 1 shows
demographic information for the patient participants and the ALSPAC
general population data. There was no significant difference between
the number of those assigned female at birth in the study population
group and the ALSPAC group (respectively, 52% vs. 51%, p = .662).
3.1.2 | Findings in group with diagnoses of mental
health disorders and neurodevelopmental conditions
Most commonly, patients had received a diagnosis of depression
(n = 129, 34%). This was followed by anxiety (n = 77, 20%), bipolar
affective disorder (n = 66, 18%), and a personality disorder (n = 45,
12%)—see Table 2.
Patients who used mental health services often received more
than one diagnosis for co-occurring disorders. Most commonly,
patients experienced anxiety and depression concurrently (n = 39).
Thirteen patients also experienced anxiety in co-occurrence with
other conditions, and 13 patients experienced depression in co-
occurrence with other conditions—see Table S1.
3.2 | Generalized joint laxity (hypermobility)
Of individuals with mental health disorders or neurodevelopmental
conditions, 142/377 scored ≥4 on the Beighton score; that is, 38%
had GJL (hypermobility). In the general population (ALSPAC) compari-
son group, 1,156/6,022 scored 4 or more on the Beighton score; that
is, 19% (Figure 1). There was a significant association between these
groups as to whether participants had joint laxity or not χ2(1) = 74.84,
p < .001. The odds ratio of having GJL was 2.54 times higher (95% CI:
2.05, 3.16) if individuals had diagnoses of mental health disorders
and/or neurodevelopmental conditions compared to those in the gen-
eral population (ALSPAC) sample.
As expected, being assigned female at birth was associated with
GJL in both patients and the general population, χ2(1) = 24.75,
p < .001, χ2(1) = 286.37, p < .001 respectively (Figure 2). The odds of
patients having GJL were 2.96 times higher (95% CI: 1.91, 4.59) if
they were assigned female at birth compared to assigned male at













38.9 (11.9) 13.8 (NR)
Sex, female (%
of group)
196 (52%) 3,061 (51%)
Abbreviations: ALSPAC, Avon Longitudinal Study of Parents and Children;
M, mean; NR, not reported.





Bipolar affective disorder 66 (18%)
Schizophrenia 38 (10%)
Personality disorder 46 (12%)
ADHD 60 (16%)
Other 59 (16%)
Note: Due to co-occurring conditions, percentages will not add to 100%.
Abbreviation: ADHD, attention deficit hyperactivity disorder.
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birth. The odds of people in the general population having GJL were
3.2 times higher (95% CI: 2.78, 3.68) if they were assigned female at
birth compared to assigned male at birth (Table 3).
3.3 | Mental health disorders, neurodevelopmental
conditions, and GJL
Joint hypermobility was overrepresented in some mental health con-
ditions more than others (i.e., anxiety, depression, and bipolar affec-
tive disorder χ2[1] = 60.19, p < .001, χ2[1] = 66.27, p < .001, χ2
[1] = 12.31, p < .001—see Table 4). The odds of experiencing GJL
compared to the general population was 5.05 times higher (95% CI:
3.21, 7.95) if someone had a diagnosis of anxiety, 3.9 times higher
(95% CI: 1.26, 5.54) if someone had a diagnosis of depression and 2.4
times higher with a diagnosis of bipolar affective disorder (95% CI:
1.45, 3.99).
3.4 | Relationships between autonomic symptoms
and GJL
Within the participant group with mental health disorders or neu-
rodevelopmental conditions, some AQQoL symptom subscale scores
were significantly higher in individuals with GJL compared to those
without GJL (p < .005, see Table 1). These specifically included
orthostatic intolerance score (p = .006), gastrointestinal symptom
score (p = .009), and total symptom score (p = .002) (Figure 3,
Table 5).
3.4.1 | Impact of sex and GJL on autonomic
symptoms
Overall, there was a significant main effect of sex on each type of
autonomic symptom subscale tested (Table 6). These indicated that
those assigned female at birth had significantly higher total symptom
scores (Figure 4), autonomic symptom scores, orthostatic intolerance
scores, and gastrointestinal scores compared to those assigned male
at birth.
3.4.2 | Mediation of relationship between
hypermobility and anxiety by orthostatic intolerance
There was a significant indirect effect of hypermobility on anxiety
diagnosis through orthostatic intolerance symptoms score, b = .1302,
BCa CI [0.0245, 0.2701] (Figure 5), indicating that such dysautonomia
mediates the relationship between joint hypermobility and anxiety.
4 | DISCUSSION
To our knowledge, this is the first study to investigate symptomatic
autonomic dysfunction in connection with variant connective tissue
(represented by GJL) in people accessing mental health services with
diagnoses of mental health disorders or neurodevelopmental condi-
tions. Significantly more patients with mental health disorders and/or
neurodevelopmental conditions experienced GJL compared to the
general population (here represented by a younger cohort), and GJL
was significantly more likely to be experienced in those assigned
female at birth. Overall, as hypothesized, autonomic dysfunction was
significantly more prevalent in patient participants with GJL compared
to those without GJL. Those assigned female at birth were shown to
display significantly more autonomic symptoms compared to those
assigned male, irrespective of having GJL, and these sex differences in
symptoms warrant further exploration in the future. Our findings indi-
cate that autonomic dysfunction (as demonstrated by symptoms of
F IGURE 1 Percentage of individuals in each group who had
generalized joint laxity. Error bars show 95% CI
F IGURE 2 Percentage of participants who had generalized joint
laxity within each sex across group. Error bars show 95% CI
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orthostatic intolerance) mediate the relationship between hyper-
mobility and anxiety status in this group.
In people accessing mental health services with diagnosed mental
health disorders or neurodevelopmental conditions, 38% had GJL
compared to 19% of the general population sample (i.e., the odds ratio
of GJL was 2.54 higher if individuals were a patient). GJL was particu-
larly likely in people diagnosed with anxiety and/or depression
(approximately twice as likely compared to not having either of these
diagnoses). These findings replicate previous research, demonstrating
that people with hypermobility are significantly more likely to experi-
ence anxiety (Bulbena et al., 2011; Bulbena et al., 2017; Smith
et al., 2014) and, to a lesser extent, depression (Smith et al., 2014).
Although an association between hypermobility and bipolar affective
disorder has been described in a population registry (Cederlöf
et al., 2016), this is the first clinical study to show over-representation
of hypermobility in those with bipolar affective disorder.
These findings underline the importance of clinical services in
considering both physical and psychological health in combination
(Bulbena et al., 2017), not least because people with symptomatic
hypermobility are at increased likelihood of experiencing pain and
multi-systemic challenges in addition to mental health difficulties.
Hypermobility may explain why some people may be at increased risk
TABLE 3 Demographics of patient participants split by hypermobility
Characteristics Hypermobile participants (n = 142) Non-hypermobile participants (n = 235)
Age in years (M, SD) 35.03 (10.98) 41.23 (11.8)
Sex, female (% of group) 97 (68.3%) 99 (42.1%)
Beighton score/9 (M, SD) 5.74 (1.68) 0.9 (1.08)
Abbreviation: M, mean.
TABLE 4 Association between GJL and mental health disorders and neurodevelopmental conditions
95% CI
Hypermobile (n, %) Non-hypermobile (n, %) Chi-square df p Odds ratio Lower Upper
Anxiety 42 (54.5%) 35 (45.5%) 60.19 1 <.001* 5.05 3.21 7.95
Depression 62 (48%) 67 (52%) 66.27 1 <.001* 3.90 1.26 5.54
Bipolar affective disorder 24 (36%) 42 (64%) 12.31 1 <.001* 2.41 1.45 3.99
Schizophrenia 2 (5%) 36 (95%) 4.74 1 <.029* 0.234 0.06 0.97
ADHD 28 (47%) 32 (53%) 28.60 1 <.001* 3.68 2.21 6.14
Personality disorder 13 (28%) 33 (72%) 2.67 1 .101 1.71 0.90 3.27
Note: Percentage is calculated within diagnosis category.
Abbreviations: ADHD, attention deficit hyperactivity disorder; CI, confidence interval; GJL, generalized joint laxity.
*p ≤ 0.05.
F IGURE 3 Graph shows the mean
symptom scores measured using the
Autonomic Questionnaire and Quality of
Life Score (AQQoL) split by hypermobility.
Error bars show ±1 SEM
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TABLE 6 Differences in symptom scores between sexes and GJL status (ANOVAs)
Variance across sexes and
hypermobility status Effect of sex on outcome




Total score F(3, 370) = 0.33, p = .802 F(1, 370) = 27.91,
p < .001*, r = 0.28
p > .05 p = .097
Autonomic symptom
score
F(3, 370) = 0.05, p = .984 F(1, 370) = 27.34,
p < .001*, r = 0.26
p > .05 p > .05
Orthostatic
intolerance score
F(3, 371) = 0.03, p = .994 F(1, 371) = 29.3, p < .001*,
r = 0.27
p > .05 p > .05
Gastrointestinal
score
F(3, 370) = 2.21, p = .086 F(1, 370) = 25.44,
p < .001*, r = 0.26
p > .05 p > .05
Bladder score F(3, 371) = 1.77, p = .152 F(1, 371) = 10.23,
p = .002*
F(1, 371) = 6.79,
p = .010
p > .05
Note: Where outcome scores were not normally distributed, these were transformed using a square root transformation prior to analysis. Where
transformations did not reveal normal distributions, attention was paid to the Levene's test to ensure variances were equal.
Abbreviations: ANOVAs, analyses of variance; GJL, generalized joint laxity.
*Shows significant result (p < .05).
F IGURE 4 Graph shows the
relationship between hypermobility and
sex on square root transformed total
symptom score. Error bars show ±1 SEM
TABLE 5 Differences in symptom scores between individuals with and without generalized joint laxity (Mann–Whitney U tests)
Mean (SD), median for hypermobile
participants
Mean (SD), median for non-
hypermobile participants U z p r
OI/120 31.96 (18.96), 31 26.85 (17.65), 24 19,309.5 2.77 .006* 0.14
GI/36 10.86 (7.51), 10 8.83 (6.72), 7 19,033.5 2.63 .009* 0.14
Bladder/28 4.52 (5.39), 3 5.54 (5.28), 4 14,137.5 2.36 .018* 0.12
Secretomotor/16 3.24 (2.69), 3 2.97 (2.53), 3 17,283.5 0.791 .429
Sudomotor/44 10.17 (10.34), 7 9.89 (9.51), 7 16,392 0.104 .917
Autonomic subscale
score/249
62.81 (36.3), 57.5 56.2 (33.54), 51.5 18,202 1.801 .072
MSK symptom
score/14
7.87 (3.99), 7 6.89 (4.37), 6 18,962.5 2.43 .015* 0.13
Total score/272 76.44 (39.18), 71 36.99 (36.15), 59.5 19,500.5 3.08 .002* 0.16
Abbreviations: GI, gastrointestinal; MSK, musculoskeletal; OI, orthostatic intolerance; r, effect size measure.
*Shows when p < .05.
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of developing anxiety disorders (Davies et al., 2021; Eccles
et al., 2012; Eccles et al., 2015). We have demonstrated that this risk
is mediated by autonomic dysfunction and is likely to represent a
complex interplay of brain–body factors involving the influence of
autonomic and interoceptive control on neural and emotional
processing. These observations offer potential novel treatment targets
(Davies et al., 2021; Quadt et al., 2021).
Therefore, screening for autonomic dysfunction and physical
health problems in people with both mental health difficulties and GJL
could be especially important in the context of the known increased
likelihood of physical health problems in people with mental health
problems generally, both to help improve overall health and associ-
ated morbidity (Liu et al., 2017; Osborn, 2001).
Our central hypothesis was supported; individuals with mental
health disorders or neurodevelopmental conditions and GJL were
more likely to report symptoms of autonomic dysfunction. This was
shown to be particularly important in relation to symptoms of ortho-
static intolerance, gastrointestinal, and musculoskeletal symptoms.
Our findings extend previous observations in people with diagnosed
symptomatic hypermobility (Celletti et al., 2017; Chan et al., 2019;
Hakim & Grahame, 2004; Zarate et al., 2010), for whom orthostatic
intolerance and gastrointestinal symptoms represent arguably the
most common autonomic dysfunction difficulties (Dojcinovska,
Cohen, & Wolman, 2019). This is crucial to consider due to the associ-
ated burden on quality of life (Fikree et al., 2017; Hakim et al., 2017)
for individuals with GJL, and the potential impact of these symptoms
on their mental health. For instance, orthostatic intolerance could lead
people to experience anxiety related to possibly fainting in public.
Syncope and PoTS have clear management guidelines and treatment
and could substantially improve both patients' physical and mental
health. Gastrointestinal difficulties could lead to increased symptoms
of depression if people isolate themselves and avoid going out due to
worries about how to manage these symptoms in public (Kopczynska,
Mokros, Pietras, & Małecka-Panas, 2018). Therefore, it is important to
investigate the prevalence of such difficulties in combination with
psychological and mental health challenges due to the need to
develop an accurate holistic understanding of an individual's difficul-
ties, to ensure that targeted and appropriate interventions are
implemented.
The difference in sex in the groups with and without GJL is a pos-
sible limitation of this study which should be rectified in future
research. Further exploration of the effect of medication on auto-
nomic symptoms in such a group is warranted including formal auto-
nomic function tests to explore the degree and severity of
cardiovascular and sudomotor dysfunction. A further difficulty is the
heterogenous nomenclature regarding hypermobility. This study
quantified generalized joint laxity rather particular diagnoses of symp-
tomatic hypermobility such as hEDS, and further work on the preva-
lence and role of hEDS in such multimorbidity is warranted, including
the use of hEDS criteria variable Beighton cut-offs. It is important to
consider that it is possible to have minimal joint symptoms and signifi-
cant associated morbidity in other systems.
We have demonstrated that patients with mental health disorders
and/or neurodevelopmental conditions have high rates of joint hyper-
mobility and autonomic dysfunction, which in turn mediates the
association between joint hypermobility and anxiety status in this
group. Increased awareness and understanding of this process may




F IGURE 5 (a) Significant relationship between orthostatic intolerance symptoms and anxiety status. (b) Significant relationship between
orthostatic intolerance symptoms (error bars = 1 SEM). (c) Model of hypermobility as a predictor of anxiety diagnosis, mediated by orthostatic
intolerance symptoms. The confidence interval (CI) for the indirect effect is a BCa bootstrapped CI based on 1,000 samples
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multimorbidity, particularly co-occurring physical symptoms and men-
tal health difficulties in the context of variant connective tissue.
ACKNOWLEDGMENTS
We would like to thank the Research and Development team at Sus-
sex Partnership NHS Foundation Trust and Rosie Mulgrue.
CONFLICTS OF INTEREST
No conflicts of interest.
AUTHOR CONTRIBUTIONS
The study was designed by Jessica A. Eccles and Hugo D. Critchley
with assistance from Christopher J. Mathias and Valeria Iodice. Jenny
L. L. Csecs and Jessica A. Eccles drafted the initial manuscript and
conducted data analysis. Nicholas G. Dowell and Georgia K. Savage
assisted with data analysis and visualization. All authors contributed
to the drafting of the manuscript.
DATA AVAILABILITY STATEMENT
Anonymized datasets available on reasonable request to the
corresponding author.
ORCID
Jessica A. Eccles https://orcid.org/0000-0002-0062-1216
REFERENCES
Baeza-Velasco, C., Sinibaldi, L., & Castori, M. (2018). Attention-
deficit/hyperactivity disorder, joint hypermobility-related disorders
and pain: Expanding body-mind connections to the developmental
age. ADHD Attention Deficit and Hyperactivity Disorders, 10, 163–175.
https://doi.org/10.1007/s12402-018-0252-2
Beighton, P., Solomon, L., & Soskolne, C. (1973). Articular mobility in an
African population. Annals of the Rheumatic Diseases, 32(5), 413.
Bulbena, A., Baeza-Velasco, C., Bulbena-Cabré, A., Pailhez, G.,
Critchley, H., Chopra, P., … Porges, S. (2017). Psychiatric and psycho-
logical aspects in the Ehlers-Danlos syndromes. American Journal of
Medical Genetics. Part C, Seminars in Medical Genetics, 175(1), 237–
245. https://doi.org/10.1002/ajmg.c.31544
Bulbena, A., Gago, J., Pailhez, G., Sperry, L., Fullana, M. A., & Vilarroya, O.
(2011). Joint hypermobility syndrome is a risk factor trait for anxiety
disorders: A 15-year follow-up cohort study. General Hospital Psychia-
try, 33(4), 363–370. https://doi.org/10.1016/j.genhosppsych.2011.
03.004
Castori, M. (2012). Ehlers-Danlos syndrome, hypermobility type: An
underdiagnosed hereditary connective tissue disorder with mucocuta-
neous, articular, and systemic manifestations. ISRN Dermatology, 2012,
1–22. https://doi.org/10.5402/2012/751768
Cederlöf, M., Larsson, H., Lichtenstein, P., Almqvist, C., Serlachius, E., &
Ludvigsson, J. F. (2016). Nationwide population-based cohort study of
psychiatric disorders in individuals with Ehlers–Danlos syndrome or
hypermobility syndrome and their siblings. BMC Psychiatry, 16(1), 207.
https://doi.org/10.1186/s12888-016-0922-6
Celletti, C., Camerota, F., Castori, M., Censi, F., Gioffrè, L., Calcagnini, G., &
Strano, S. (2017). Orthostatic intolerance and postural orthostatic
tachycardia syndrome in joint hypermobility syndrome/Ehlers-Danlos
syndrome, hypermobility type: Neurovegetative dysregulation or auto-
nomic failure? BioMed Research International, 2017, 9161865. https://
doi.org/10.1155/2017/9161865
Chan, C., Krahe, A., Lee, Y. T., & Nicholson, L. L. (2019). Prevalence and
frequency of self-perceived systemic features in people with joint
hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type.
Clinical Rheumatology, 38(2), 503–511. https://doi.org/10.1007/
s10067-018-4296-7
Clinch, J., Deere, K., Sayers, A., Palmer, S., Riddoch, C., Tobias, J. H., &
Clark, E. M. (2011). Epidemiology of generalized joint laxity (hyper-
mobility) in fourteen-year-old children from the UK: A population-
based evaluation. Arthritis and Rheumatism, 63(9), 2819–2827. https://
doi.org/10.1002/art.30435
Critchley, H. D. (2009). Psychophysiology of neural, cognitive and affective
integration: fMRI and autonomic indicants. International Journal of Psycho-
physiology, 73(2), 88–94. https://doi.org/10.1016/j.ijpsycho.2009.01.012
Csecs, J. L. L., Lodice, V., Rae, C. L., Brooke, A., Simmons, R., Dowell, N. G.,
…, Eccles, J. A. (2020). Increased rate of joint hypermobility in autism
and related neurodevelopmental conditions is linked to dysautonomia
and pain. medRxiv. https://doi.org/10.1101/2020.09.14.20194118
Davies, G., Csecs, J. L., Ball, H., Dare, J., Bremner, S., Hosking, R., …
Eccles, J. A. (2021). Altering dynamics of autonomic processing ther-
apy (ADAPT) trial: A novel, targeted treatment for reducing anxiety in
joint hypermobility. Trials, 22(1), 1–10. https://doi.org/10.1186/
s13063-021-05555-4
De Wandele, I., Calders, P., Peersman, W., Rimbaut, S., De Backer, T.,
Malfait, F., … Rombaut, L. (2014). Autonomic symptom burden in the
hypermobility type of Ehlers–Danlos syndrome: A comparative study
with two other EDS types, fibromyalgia, and healthy controls. Seminars
in Arthritis and Rheumatism, 44(3), 353–361. https://doi.org/10.1016/
j.semarthrit.2014.05.013
De Wandele, I., Rombaut, L., Leybaert, L., Van de Borne, P., De Backer, T.,
Malfait, F., … Calders, P. (2014). Dysautonomia and its underlying
mechanisms in the hypermobility type of Ehlers–Danlos syndrome.
Seminars in Arthritis and Rheumatism, 44(1), 93–100. https://doi.org/
10.1016/j.semarthrit.2013.12.006
Demmler, J. C., Atkinson, M. D., Reinhold, E. J., Choy, E., Lyons, R. A., &
Brophy, S. T. (2019). Diagnosed prevalence of Ehlers-Danlos syndrome
and hypermobility spectrum disorder in Wales, UK: A national elec-
tronic cohort study and case–control comparison. BMJ Open, 9(11),
e031365. https://doi.org/10.1136/bmjopen-2019-031365
Dojcinovska, M., Cohen, H., & Wolman, R. (2019). 200 Demographics and
clinical characteristics of a national cohort of 280 patients with hyper-
mobility syndrome and impact on their work disability. Rheumatology,
58(Suppl. 3), iii123–iii124. https://doi.org/10.1093/rheumatology/
kez107.016
Eccles, J. A., Beacher, F. D., Gray, M. A., Jones, C. L., Minati, L.,
Harrison, N. A., & Critchley, H. D. (2012). Brain structure and joint
hypermobility: Relevance to the expression of psychiatric symptoms.
The British Journal of Psychiatry, 200(6), 508–509. https://doi.org/10.
1192/bjp.bp.111.092460
Eccles, J. A., & Davies, K. A. (2021). The challenges of chronic pain and
fatigue. Clinical Medicine (London, England), 21(1), 19–27. https://doi.
org/10.7861/clinmed.2020-1009
Eccles, J. A., Owens, A. P., Mathias, C. J., Umeda, S., & Critchley, H. D.
(2015). Neurovisceral phenotypes in the expression of psychiatric
symptoms. Frontiers in Neuroscience, 9, 4. https://doi.org/10.3389/
fnins.2015.00004
Fikree, A., Chelimsky, G., Collins, H., Kovacic, K., & Aziz, Q. (2017). Gastro-
intestinal involvement in the Ehlers-Danlos syndromes. American Jour-
nal of Medical Genetics Part C: Seminars in Medical Genetics, 175(1),
181–187. https://doi.org/10.1002/ajmg.c.31546
Goh, M., Olver, J., Huang, C., Millard, M., & O'Callaghan, C. (2013). Preva-
lence and familial patterns of gastrointestinal symptoms, joint hyper-
mobility and diurnal blood pressure variations in patients with
anorexia nervosa. Journal of Eating Disorders, 1(Suppl. 1), O45. https://
doi.org/10.1186/2050-2974-1-S1-O45
CSECS ET AL. 9
Hakim, A., O'Callaghan, C., De Wandele, I., Stiles, L., Pocinki, A., &
Rowe, P. (2017). Cardiovascular autonomic dysfunction in Ehlers-
Danlos syndrome—Hypermobile type. American Journal of Medical
Genetics Part C: Seminars in Medical Genetics, 175(1), 168–174.
https://doi.org/10.1002/ajmg.c.31543
Hakim, A. J., & Grahame, R. (2004). Non-musculoskeletal symptoms in
joint hypermobility syndrome. Indirect evidence for autonomic dys-
function? Rheumatology, 43(9), 1194–1195.
Hakim, A. J., Malfait, F., & De Paepe, A. (2010). The heritable disorders of
connective tissue: Epidemiology, nosology and clinical features. In A. J.
Hakim, R. Keer, & R. Grahame (Eds.), Hypermobility, fibromyalgia and
chronic pain (pp. 3–17). Edinburgh: Elsevier Health Sciences.
Hayes, A. F. (2017). Introduction to mediation, moderation, and conditional
process analysis: A regression-based approach. New York: Guilford
Publications.
Iodice, V. (2013). The postural tachycardia syndrome: A multi-system con-
dition. Clinical features, pathophysiology, genetics and novel treat-
ment. (PhD), Imperial College London. Retrieved from http://hdl.
handle.net/10044/1/38561
Junge, T., Henriksen, P., Hansen, S., Østengaard, L., Golightly, Y. M., &
Juul-Kristensen, B. (2019). Generalised joint hypermobility and knee
joint hypermobility: Prevalence, knee joint symptoms and health-
related quality of life in a Danish adult population. International Journal
of Rheumatic Diseases, 22(2), 288–296. https://doi.org/10.1111/
1756-185X.13205
Juul-Kristensen, B., Østengaard, L., Hansen, S., Boyle, E., Junge, T., &
Hestbaek, L. (2017). Generalised joint hypermobility and shoulder joint
hypermobility,  Risk of upper body musculoskeletal symptoms and
reduced quality of life in the general population. BMC Musculoskeletal
Disorders, 18(1), 226. https://doi.org/10.1186/s12891-017-1595-0
Kopczynska, M., Mokros, Ł., Pietras, T., & Małecka-Panas, E. (2018). Qual-
ity of life and depression in patients with irritable bowel syndrome.
Przeglad Gastroenterologiczny, 13(2), 102–108. https://doi.org/10.
5114/pg.2018.75819
Kumar, B., & Lenert, P. (2017). Joint hypermobility syndrome: Recognizing
a commonly overlooked cause of chronic pain. The American Journal of
Medicine, 130(6), 640–647. https://doi.org/10.1016/j.amjmed.2017.
02.013
Liu, N. H., Daumit, G. L., Dua, T., Aquila, R., Charlson, F., Cuijpers, P., …
Saxena, S. (2017). Excess mortality in persons with severe mental dis-
orders: A multilevel intervention framework and priorities for clinical
practice, policy and research agendas. World Psychiatry, 16(1), 30–40.
https://doi.org/10.1002/wps.20384
Mallorqui-Bague, N., Garfinkel, S. N., Engels, M., Eccles, J. A., Pailhez, G.,
Bulbena, A., & Critchley, H. D. (2014). Neuroimaging and psychophysi-
ological investigation of the link between anxiety, enhanced affective
reactivity and interoception in people with joint hypermobility. Frontiers
in Psychology, 5, 1162. https://doi.org/10.3389/fpsyg.2014.01162
Manikandan, S. (2010). Data transformation. Journal of Pharmacology &
Pharmacotherapeutics, 1(2), 126–127. https://doi.org/10.4103/0976-
500X.72373
Mathias, C. J., Low, D. A., Iodice, V., Owens, A. P., Kirbis, M., &
Grahame, R. (2011). Postural tachycardia syndrome—Current experi-
ence and concepts. Nature Reviews. Neurology, 8(1), 22–34. https://
doi.org/10.1038/nrneurol.2011.187
Mulvey, M. R., Macfarlane, G. J., Beasley, M., Symmons, D. P., Lovell, K.,
Keeley, P., … McBeth, J. (2013). Modest association of joint hyper-
mobility with disabling and limiting musculoskeletal pain: Results from
a large-scale general population-based survey. Arthritis Care &
Research, 65(8), 1325–1333.
National Institute for Health and Care Excellence. (2018). Multimorbidity.
Retrieved from https://cks.nice.org.uk/topics/multimorbidity/
Osborn, D. P. (2001). The poor physical health of people with mental ill-
ness. The Western Journal of Medicine, 175(5), 329–332. https://doi.
org/10.1136/ewjm.175.5.329
Quadt, L., Garfinkel, S. N., Mulcahy, J. S., Larsson, D. E., Silva, M.,
Jones, A. M., … Critchley, H. D. (2021). Interoceptive training to target
anxiety in autistic adults (ADIE): A single-center, superiority random-
ized controlled trial. EClinicalMedicine, 39, 101042. https://doi.org/10.
1016/j.eclinm.2021.101042
Reuter, P. R., & Fichthorn, K. R. (2019). Prevalence of generalized joint
hypermobility, musculoskeletal injuries, and chronic musculoskeletal
pain among American university students. PeerJ, 7, e7625–e7625.
https://doi.org/10.7717/peerj.7625
Seth, A. K., Suzuki, K., & Critchley, H. D. (2011). An interoceptive predic-
tive coding model of conscious presence. Frontiers in Psychology, 2,
395. https://doi.org/10.3389/fpsyg.2011.00395
Smith, C. (2017). Understanding hypermobile Ehlers-Danlos syndrome and
hypermobility spectrum disorder. Somerset, UK: Redcliff-House
Publications.
Smith, T. O., Easton, V., Bacon, H., Jerman, E., Armon, K., Poland, F., &
Macgregor, A. J. (2014). The relationship between benign joint hyper-
mobility syndrome and psychological distress: A systematic review and
meta-analysis. Rheumatology (Oxford), 53(1), 114–122. https://doi.org/
10.1093/rheumatology/ket317
Sobey, G. (2015). Ehlers–Danlos syndrome: How to diagnose and when to
perform genetic tests. Archives of Disease in Childhood, 100(1), 57–61.
https://doi.org/10.1136/archdischild-2013-304822
Stewart, J. M. (2013). Common syndromes of orthostatic intolerance. Pedi-
atrics, 131(5), 968–980. https://doi.org/10.1542/peds.2012-2610
Wang, A. K., Fealey, R. D., Gehrking, T. L., & Low, P. A. (2008). Patterns of
neuropathy and autonomic failure in patients with amyloidosis. Mayo
Clinic Proceedings, 83(11), 1226–1230. https://doi.org/10.4065/83.11.
1226
Wells, R., Spurrier, A. J., Linz, D., Gallagher, C., Mahajan, R., Sanders, P., …
Lau, D. H. (2018). Postural tachycardia syndrome: Current perspec-
tives. Vascular Health and Risk Management, 14, 1–11. https://doi.org/
10.2147/vhrm.S127393
Whitty, C. J. M., MacEwen, C., Goddard, A., Alderson, D., Marshall, M.,
Calderwood, C., … Marx, C. (2020). Rising to the challenge of mul-
timorbidity. BMJ, 368, l6964. https://doi.org/10.1136/bmj.l6964
Zarate, N., Farmer, A. D., Grahame, R., Mohammed, S. D., Knowles, C. H.,
Scott, S. M., & Aziz, Q. (2010). Unexplained gastrointestinal symptoms
and joint hypermobility: Is connective tissue the missing link? Neuro-
gastroenterology and Motility, 22(3), 252–e278. https://doi.org/10.
1111/j.1365-2982.2009.01421.x
SUPPORTING INFORMATION
Additional supporting information may be found in the online version
of the article at the publisher's website.
How to cite this article: Csecs, J. L. L., Dowell, N. G., Savage,
G. K., Iodice, V., Mathias, C. J., Critchley, H. D., & Eccles, J. A.
(2021). Variant connective tissue (joint hypermobility) and
dysautonomia are associated with multimorbidity at the
intersection between physical and psychological health.
American Journal of Medical Genetics Part C: Seminars in
Medical Genetics, 1–10. https://doi.org/10.1002/ajmg.c.31957
10 CSECS ET AL.
